Source:http://linkedlifedata.com/resource/pubmed/id/21960936
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2011-9-30
|
pubmed:abstractText |
Porphyrias are a group of metabolic disorders resulting from enzymatic defects in the heme biosynthetic pathway. Erythropoietic protoporphyria is thought to be the second most common porphyria seen in clinical practice. It is, however, commonly under-recognized and can lead to both cutaneous manifestations as well as derangement in hepatic function in a minority of patients. This review summarizes the current understanding of this disorder. Different treatment options are discussed with the goal of preventing liver damage. The roles of liver and bone marrow transplantation are also addressed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1554-7914
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
561-6
|
pubmed:year |
2008
|
pubmed:articleTitle |
The diagnosis and management of erythropoietic protoporphyria.
|
pubmed:affiliation |
Dr. Thapar is Clinical Instructor of Medicine in the Division of Gastroenterology and Hepatology at the University of Missouri in Columbia, Missouri. Dr. Bonkovsky serves as Professor of Medicine at the University of Connecticut Health Center in Farmington, Connecticut, Adjunct Professor of Medicine at the University of North Carolina at Chapel Hill, and Adjunct Professor of Biology at the University of North Carolina at Charlotte.
|
pubmed:publicationType |
Journal Article
|